| Anti-leukemic effects of all-trans retinoic acid in combination with Daratumumab in acute myeloid leukemia NJ Buteyn, K Fatehchand, R Santhanam, H Fang, GM Dettorre, S Gautam, ... International immunology 30 (8), 375-383, 2018 | 31 | 2018 |
| Antibody conjugation of fluorescent nanodiamonds for targeted innate immune cell activation LP Suarez-Kelly, SH Sun, C Ren, IV Rampersaud, D Albertson, ... ACS applied nano materials 4 (3), 3122-3139, 2021 | 26 | 2021 |
| Activation of the intracellular pattern recognition receptor NOD2 promotes acute myeloid leukemia (AML) cell apoptosis and provides a survival advantage in an animal model of AML NJ Buteyn, R Santhanam, G Merchand-Reyes, RA Murugesan, ... The Journal of Immunology 204 (7), 1988-1997, 2020 | 25 | 2020 |
| CD31 acts as a checkpoint molecule and is modulated by FcγR-mediated signaling in monocytes G Merchand-Reyes, FH Robledo-Avila, NJ Buteyn, S Gautam, ... The Journal of Immunology 203 (12), 3216-3224, 2019 | 24 | 2019 |
| Interferon-γ promotes antibody-mediated fratricide of acute myeloid leukemia cells K Fatehchand, EL McMichael, BF Reader, H Fang, R Santhanam, ... Journal of Biological Chemistry 291 (49), 25656-25666, 2016 | 24 | 2016 |
| Structural variants involving MLLT10 fusion are associated with adverse outcomes in pediatric acute myeloid leukemia O Abla, RE Ries, T Triche Jr, RB Gerbing, B Hirsch, S Raimondi, T Cooper, ... Blood Advances 8 (8), 2005-2017, 2024 | 5 | 2024 |
| Inhibition of BET Proteins Regulates Fcγ Receptor Function and Reduces Inflammation in Rheumatoid Arthritis D Shankar, G Merchand-Reyes, NJ Buteyn, R Santhanam, H Fang, ... International journal of molecular sciences 24 (8), 7623, 2023 | 5 | 2023 |
| EZH2-mediated MHC class II silencing drives immune evasion in AML with t (16; 21)(FUS-ERG) NJ Buteyn, CG Burke, JL Smith, RE Ries, AR Leonti, TI Shaw, BJ Huang, ... Blood 138, 374, 2021 | 3 | 2021 |
| Activation of plasmacytoid dendritic cells promotes AML-cell fratricide K Fatehchand, P Mehta, CB Colvin, NJ Buteyn, R Santhanam, ... Oncotarget 12 (9), 878, 2021 | 2 | 2021 |
| Exploring Nutraceuticals to Enhance Scientific Literacy: Aligning with Vision and Change N Buteyn, YI Oh, J Knott, P Bokach, J Konyndyk, J Tenney, A Wilstermann, ... The American Biology Teacher 81 (3), 176-185, 2019 | 2 | 2019 |
| EZH2-driven immune evasion defines high-risk pediatric AML with t (16; 21) FUS:: ERG gene fusion NJ Buteyn, CG Burke, VJ Sartori, E Deering-Gardner, ZJ DeBruine, ... bioRxiv, 2024 | | 2024 |
| Reclassification of ETS Family Transcription Factor Fusions in Pediatric AML Based on Molecular Drivers NJ Buteyn, C Burke, E Gardner, VJ Sartori, RE Ries, TA Alonzo, ... Blood 142, 4298, 2023 | | 2023 |
| CD31 acts as a checkpoint molecule and is modulated by FcγR-mediated signaling in monocytes JP Butchar, G Merchand-Reyes, F Robledo-Avila, N Buteyn, S Gautam, ... The Journal of Immunology 202 (1_Supplement), 59.12-59.12, 2019 | | 2019 |
| Role of Innate Immunity Activators in the Treatment of Acute Myeloid Leukemia NJ Buteyn The Ohio State University, 2019 | | 2019 |
| Antibody Conjugation of Fluorescent Nanodiamonds for Targeted Innate Immune Cell Activation LP Suarez-Kelly, IV Rampersaud, D Albertson, E Morris, TC Noel, ... ANNALS OF SURGICAL ONCOLOGY 25, S13-S13, 2018 | | 2018 |